IATI Biomed 2015: Sanofi appoints Israel scout to find biomed start-upsMay. 14, 2015
French pharmaceuticals company Sanofi is one of the biggest players in the global pharmaceuticals industry. Sanofi VP, Global Head External Innovation Operations Adam Keeney spoke with "Globes" at the IATI Biomed 2015 convention in Tel Aviv. As head of global external innovation at Sanofi, Adam Keeney is the person responsible for partnerships with academic institutions and young companies."We have raised the bar for innovation"
"This is a very interesting time for pharmaceuticals," Keeney said, in an interview with "Globes," "Today, more and more, the approved drugs are really groundbreaking, and that was not necessarily the case in previous years. Sanofi expects to launch no fewer than six new drugs in 2015, and to launch another one every six months thereafter."
As an example, Keeney noted, "We are very excited about our partnership with Regeneron, which has yielded an antibody to reduce cholesterol levels. A few different companies competed to launch the first biological drug against cholesterol, which is intended for people who are unable to tolerate the existing drugs, or for whom they are not effective. Sanofi is currently ahead of the competition, and its product is expected to be approved this year. "In vaccines, we developed a vaccine for Dengue Fever, a very lethal tropical disease. We believe that we can really eradicate it."
Q: What have you done organizationally to improve R&D?
"We raised the bar for innovation. If, in the past, the team was satisfied with incremental innovation, we have now made it clear that the research emphasis must be on real scientific breakthroughs. In addition, we have placed more emphasis on partnerships. We established research centers where our researchers operate in very productive scientific environments, and we encourage them to forge strong ties with academic institutions in their fields and with young companies. In my opinion, the entire industry has taken a step up in terms of innovation."
For the full Globes interview click here.